Champions Oncology - End to End Pharmacology Solutions

End to End Pharmacology Solutions
Bridging the Gap Between Research and Clinic

Leverage a range of research and development solutions to improve the productivity of oncology drug development

First Annual Boston Symposium
September 19, 2019

Translational Oncology and Clinical Flow Cytometry Tracks

PDX Model Spotlight
EX20 EGFR Mutant Models

Now Enrolling - Champions SynScreen
Enrollment Ends September 30th

Now Including 16 Channel Flow Cytometry Capabilities

Champions 50 Model Solid Tumor PDX in Vivo Screen
Enrollment Ends August 31st

Participate in the Champions Oncology PDX Indication Screen for lower cost, large scale PDX pharmacology studies

AACR 2019 Poster Presentation

AML PDX Platform to Evaluate Novel Therapeutic Agents

Our Latest Webinar

Clinical Flow Cytometry: Validation and Implementation in a Regulatory Setting

On-Demand Webinar Series

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Access the Champions TumorGraft Database

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Read Our Latest Newsletter

Hematology
Oncology Models

Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations

Champions Oncology Reports Record Quarterly Revenue of $6.2 Million